nasal mucilairtm in vitro models (Epithelix)
Structured Review
Nasal Mucilairtm In Vitro Models, supplied by Epithelix, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vitro+model/in+models+mucilairtm+nasal+vitro/pm42285446-76-0-35
Average 86 stars, based on 1 article reviews
Images
Related Articles
Infection:Article Title: Metavac-RSV mucosal bivalent vaccine candidate protects cotton rats against pneumoviruses and is produced using serum-free cell culture in bioreactor. Article Snippet: Diameter of Metavac®-RSV particles was measured on transmission electron microscopy pictures (n = 58 for bioreactor production and n = 30 for static production). .. Infection of reconstituted In Vitro:Article Title: Metavac-RSV mucosal bivalent vaccine candidate protects cotton rats against pneumoviruses and is produced using serum-free cell culture in bioreactor. Article Snippet: Diameter of Metavac®-RSV particles was measured on transmission electron microscopy pictures (n = 58 for bioreactor production and n = 30 for static production). .. Infection of reconstituted Article Title: Preclinical in vitro evaluation of a new nasal formulation combining xylometazoline and hyaluronic acid: Permeability and penetration analysis using an advanced characterized human nasal model. Article Snippet: A new nasal formulation combining xylometazoline, a well-established nasal decongestant, and hyaluronic acid (HA) at a 3 mg/ml concentration and low-molecular-weight has been developed as a topical product intended for use in viral acute rhinosinusitis, with the aim of relieving nasal congestion and supporting epithelial integrity.. HA, a moisturizing component of respiratory secretions, has been shown to promote epithelial integrity, stimulate mucociliary clearance and support wound healing.. As part of the drug development process, this study investigated the permeation and penetration properties of xylometazoline, and HA in the new formulation using a human nasal epithelium in vitro model. Derivative Assay:Article Title: Metavac-RSV mucosal bivalent vaccine candidate protects cotton rats against pneumoviruses and is produced using serum-free cell culture in bioreactor. Article Snippet: Diameter of Metavac®-RSV particles was measured on transmission electron microscopy pictures (n = 58 for bioreactor production and n = 30 for static production). .. Infection of reconstituted |


